Pfizer Inc executives on Tuesday expressed measured optimism over the prospect of providing a COVID-19 vaccine this year even as they signaled key data on the vaccine would not be released before the US presidential election on Tuesday next week.
Pfizer chief executive Albert Bourla said that the drug giant could this year supply about 40 million doses in the US if clinical testing proceeds as expected and regulators approve the vaccine.
“If all goes well, we will be ready to distribute an initial number of doses,” said Bourla, who pointed to a US government contract for Pfizer to supply 40 million doses by the end of this year and 100 million doses by March next year.
Photo: AP, Cincinnati Children Hospital Medical Center
However, Bourla said that the company had still not reached key benchmarks in assessing vaccine efficacy. Pfizer previously said that it could have the data this month, which might have advanced the process ahead of the US election.
“We have reached the last mile here,” Bourla said. “So let’s all have the patience that’s required for something so important for public health and the global economy.”
He said that the company expects to file for emergency use authorization for its COVID-19 vaccine in the third week of next month, roughly in line with earlier timetables.
Asked if he was “bullish” that the vaccine would work, Bourla said: “I’m cautiously optimistic.”
Pfizer reported a 71 percent drop in profit to US$2.2 billion in the latest quarter. However, the comparable period last year included a large gain connected to a transaction.
Revenues dipped 4 percent to US$12.1 billion, missing analyst estimates.
Pfizer estimated a revenue drop of US$500 million due to COVID-19 leading to lower pharmaceutical demand in China and fewer wellness visits by US patients.
The company posted an 11 percent drop in its hospital business in emerging markets, primarily due to fewer elective surgeries and shorter in-patient hospital stays in China.
This effect was partially offset by increased demand for the Prevnar-13 vaccine for pneumonia “resulting from greater vaccine awareness for respiratory illnesses,” the company said.
Pfizer also cited strong performance in its biopharma business due to good sales of cancer drug Ibrance, anticoagulant Eliquis and other medications.
SUPPLY CHAIN RESHUFFLE: The chipmaker was ‘cautious’ in not making commitments too early in building production in the US, citing ‘geopolitical factors,’ Nikkei Asia said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is considering building an advanced IC packaging plant in the US following a massive investment to set up a wafer fab in Arizona, Nikkei Asia reported. TSMC was considering the plant in response to “Washington’s desire to bring more of the tech supply chain onto home turf,” the report said. TSMC increasingly faces the need to expand in the US, which accounts for about 62 percent of its total sales, Nikkei Asia said, citing three sources who declined to be named. The potential US plant would be equipped with the latest 3D stacking technologies to arrange chips
MARKET BOOST: Elon Musk said Tesla would resume bitcoin transactions once there is ‘reasonable’ clean energy usage by miners and denied selling a big part of his holdings Bitcoin yesterday hit a two-week peak just shy of US$40,000, after another weekend reacting to tweets from Tesla Inc chief executive Elon Musk, who fended off criticism over his market influence and said Tesla sold bitcoin, but might resume transactions using it. Bitcoin has gyrated to Musk’s views for months since Tesla announced a US$1.5 billion bitcoin purchase in February and said it would take the cryptocurrency in payment. He later said the electric vehicle maker would not accept bitcoin due to concerns over how mining the currency requires high energy use and contributes to climate change. “When there’s confirmation of reasonable
As much as the US pines for the good old days of global semiconductor supremacy, Japan feels its loss of glory even more. Once a dominant name in electronic components, the nation has been overtaken by Taiwan, South Korea, and, more recently, China. Yet Tokyo might have a viable plan to revitalize its domestic sector. “Unlike the purely domestic, independent way it was done in the past, I think we need to cooperate with overseas counterparts,” Akira Amari, a former economy minister and senior member of the ruling Liberal Democratic Party, told Bloomberg News’ Isabel Reynolds and Emi Nobuhiro this week. That is
Apple Inc has hired Ulrich Kranz, a former senior executive at BMW AG’s electric vehicle (EV) division, to help lead its own vehicle efforts, people familiar with the situation said. The tech giant hired Kranz in recent weeks, about a month after he stepped down as CEO of Canoo Inc, a developer of self-driving EVs. Before cofounding Canoo, Kranz was senior vice president of the group that developed the i3 and i8 cars at BMW, where he worked for 30 years. Kranz is one of Apple’s most significant automotive hires, a clear sign that the iPhone maker is determined to build a